Franck Grimaud

Franck Grimaud

Director/Board Member at IOMAI CORPORATION

Net worth: 2 M $ as of 30/03/2024

58 year
Health Technology
Commercial Services
Consumer Services

Profile

Franck Charles Marie Grimaud founded Vivalis SA in 1999, where he worked as President, CEO & Head-Investor Relations from 2010 to 2013.
Mr. Grimaud also currently works at Intercell USA, Inc., as Director & Deputy Chief Executive Officer from 2015, Atlantic Biotherapies, as Chief Executive Officer & Director, Valneva USA, Inc., as Director & Deputy Chief Executive Officer from 2015, Pays de la Loire Participations, as Chairman-Governing Board from 2016, Atlanpole Biotherapies, as Chairman from 2018, Fonds Pays De La Loire Participations, as Chairman-Governing Board from 2016, Valneva Scotland Ltd., as Director from 2017, VALNEVA Austria GmbH, as Co-Managing Director from 2013, Vaccines Holdings Sweden AB, as Director & Managing Director from 2014, BliNK Biomedical SAS, as Director, Valneva Sweden AB, as Director from 2015, Valneva UK Ltd., as Director from 2015, Valneva Canada, Inc., as Director & President from 2015, Valneva SE, as Chief Business Officer, and Intercell Austria AG, as Chief Business Officer from 2013.
Mr. Grimaud also formerly worked at Vivalis Toyama Japan KK, as Chairman from 2013 to 2018, France Biotech Association, as Director, Smol Therapeutics SAS, as President & Managing Director, Grimaud Deyang Animal Co. Ltd., as Director from 2000 to 2019, and Chengdu Grimaud Breeding Co. Ltd., as Director from 2000 to 2018.
Mr. Grimaud received his Masters Business Admin degree from the University of Ottawa.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2023 635,218 ( 0.46% ) 2 M $ 30/03/2024

Franck Grimaud active positions

CompaniesPositionStart
VALNEVA Corporate Officer/Principal -
IOMAI CORPORATION Director/Board Member 30/11/2015
Director/Board Member 31/05/2017
Chairman 31/01/2018
Director/Board Member -
Director/Board Member 31/08/2016
Valneva USA, Inc. Chief Executive Officer 30/11/2015
Intercell Austria AG Corporate Officer/Principal 31/12/2012
President 31/12/2014
░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Franck Grimaud

Former positions of Franck Grimaud

CompaniesPositionEnd
░░░░░░░ ░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Franck Grimaud's experience

Training of Franck Grimaud

University of Ottawa Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Franck Grimaud's experience

Connections

54

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
VALNEVA

Health Technology

Private companies19

Health Technology

Health Technology

Commercial Services

Health Technology

Atlantic Biotherapies

Commercial Services

Smol Therapeutics SAS

Vivalis Toyama Japan KK

Grimaud Deyang Animal Co. Ltd.

Chengdu Grimaud Breeding Co. Ltd.

Commercial Services

Health Technology

Health Technology

Health Technology

Intercell Austria AG

Health Services

Distribution Services

Valneva USA, Inc.

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Franck Grimaud